Ligilactobacillus salivarius LS-33
Ligilactobacillus salivarius LS-33 (previously classified within the Lactobacillus salivarius group) appears primarily in multi-strain research, making it difficult to isolate its individual contribution from the available evidence. In vitro studies have examined intestinal epithelial tight junction integrity and immune signaling via the IL-10/IL-12 axis in dendritic cells, and animal models have examined gut microbiota in the context of colitis. Randomized trial data available involve multi-strain products rather than LS-33 alone. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 7 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 2 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
9 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 16957197 →Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model· Applied and Environmental Microbiology · 2006